Exane Derivatives’s Teva Pharmaceuticals TEVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
2022
Q1
$516 Buy
2021
Q4
Sell
2021
Q3
$536 Hold
2021
Q2
$501 Sell
2021
Q1
$127K Sell
2020
Q4
$117K Buy
2020
Q3
$88.8K Buy
2020
Q2
$64.8K Sell
2020
Q1
$405K Sell
2019
Q4
$582K Buy
2019
Q3
$365K Hold
2019
Q2
$490K Buy
2019
Q1
$146K Buy
2017
Q4
Sell
2017
Q3
$571K Buy